(Q37278382)

19 August 2017

Genomic grade index is associated with response to chemotherapy in patients with breast cancer (English)

1 reference

19 August 2017

0 references

1 reference

1 reference

Martine Piccart-Gebhart

9

Martine Piccart-Gebhart

0 references

Benjamin Haibe-Kains

5

Benjamin Haibe-Kains

0 references

Christos M. Hatzis

Christos Hatzis

2

0 references

Christine Desmedt

Christine Desmedt

4

0 references

Gabriel N Hortobagyi

8

Gabriel N Hortobagyi

1 reference

19 August 2017

10

Christos Sotiriou

1 reference

19 August 2017

11

Lajos Pusztai

1 reference

19 August 2017

María Valero de Vicente

6

Vicente Valero

1 reference

19 August 2017

Cornelia Liedtke

1

1 reference

19 August 2017

William Fraser Symmans

3

1 reference

19 August 2017

Henry Kuerer

7

1 reference

19 August 2017

language of work or name

English

0 references

publication date

13 April 2009

1 reference

Journal of Clinical Oncology

19 August 2017

1 reference

19 August 2017

27

1 reference

19 August 2017

19

1 reference

19 August 2017

3185-3191

1 reference

Evaluation of biological pathways involved in chemotherapy response in breast cancer

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716940

Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716940

Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716940

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716940

Development of pharmacogenomic markers to select preoperative chemotherapy for breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716940

Revision of the American Joint Committee on Cancer staging system for breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716940

Preoperative (neoadjuvant) chemotherapy in patients with breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716940

Molecular portraits of human breast tumours

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716940

Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716940

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716940

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716940

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716940

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716940

Prognostic factors affecting the natural history of node-negative breast cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716940

Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716940

Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome

3 September 2018

1 reference

12 December 2020

Prognostic Significance of Nottingham Histologic Grade in Invasive Breast Carcinoma

1 reference

12 December 2020

Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18

1 reference

12 December 2020

Estrogen receptors and distinct patterns of breast cancer relapse

1 reference

12 December 2020

Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer

1 reference

12 December 2020

Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer

1 reference

12 December 2020

Nuclear structure in cancer tissues

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2008.18.5934

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19364972

1 reference